Document is current

Article History

Received: 2 June 2024

Accepted: 18 December 2024

First Online: 28 December 2024

Declarations

:

: The study protocol, patient and HC information, and consent form for minors and adults were approved on June 29th, 2022, by the Ethics Committee of the University of Frankfurt (reference: 2022 − 645, Chair: Prof. Dr. Harder). Every participant or their legal guardian must give written informed consent to participate in this study.

: Not applicable.

: AR has received honoraria for lectures and/or advisory boards from Janssen, Boehringer Ingelheim, COMPASS, SAGE/Biogen, LivaNova, Medice, Shire/Takeda, MSD and cyclerion. Also, he has received research grants from Medice and Janssen. MA served on one advisory board from Janssen. JR has received honoraria for lectures from Janssen and Hexal. UE-P reports consultancy for Boehringer-Ingelheim and speaker honorarium from Angelini Pharma. J.A.R.Q was on the speakers’ bureau and/or acted as consultant for Biogen, Idorsia, Casen-Recordati, Janssen-Cilag, Novartis, Takeda, Bial, Sincrolab, Neuraxpharm, Novartis, BMS, Medice, Rubió, Uriach, Technofarma and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Idorsia, Janssen-Cilag, Rubió, Takeda, Bial and Medice. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Exeltis, Idorsia, Janssen- Cilag, Neuraxpharm, Oryzon, Roche, Probitas and Rubió. During the past three years, JH has received lecture honoraria from Medice, all outside the current work. NP has received honoraria for lectures and/or advisory boards from Medice and Shire/Takeda.